Lovastatin and Apixaban drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lovastatin (lovastatin) and Apixaban (apixaban). Common drug interactions include chronic kidney disease among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Lovastatin and Apixaban. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.

What is Lovastatin?

Lovastatin has active ingredients of lovastatin. It is often used in high blood cholesterol. eHealthMe is studying from 33,048 Lovastatin users. Check the latest studies of Lovastatin.

What is Apixaban?

Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,351 Apixaban users. Check the latest studies of Apixaban.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

100 people who take Lovastatin and Apixaban together, and have interactions are studied.

Lovastatin and Apixaban drug interactions.

What are the common drug interactions of Lovastatin and Apixaban, by gender? *:

female:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal tubular necrosis (death of kidney tubules)
Aphasia (damage to the parts of the brain that control language)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Fatigue (feeling of tiredness)
Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
Memory impairment
Osteoporosis (bones weak and more likely to break)
Renal failure (kidney dysfunction)

male:

Dizziness
Nausea (feeling of having an urge to vomit)
Death
Apnoea (suspension of external breathing)
Arthralgia (joint pain)
Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body)
Asthenia (weakness)
Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
Cough
Depressed mood

What are the common drug interactions of Lovastatin and Apixaban, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Renal failure (kidney dysfunction)
Nephropathy (damage to or disease of a kidney)

40-49:

n/a

50-59:

Cardiac disorder
Skin burning sensation

60+:

Diarrhoea
Palmar-plantar erythrodysaesthesia syndrome (hand-foot syndrome)
Conjunctivitis (pink eye)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Subdural haematoma (blood collects between the skull and the surface of the brain)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hypotension (abnormally low blood pressure)
Memory impairment
Muscle spasms (muscle contraction)
Tremor (trembling or shaking movements in one or more parts of your body)

What are the existing conditions these people have? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 25 people, 25.00%
High Blood Pressure: 10 people, 10.00%
Pain: 9 people, 9.00%
Constipation: 9 people, 9.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 9.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 7.00%
Depression: 7 people, 7.00%
Parkinson's Disease: 6 people, 6.00%
Embolism Venous (embolus may pass into the arterial system): 5 people, 5.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 5 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Lovastatin and Apixaban?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously